-
In this issue: Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
-
Successful shared decision-making requires three key elements: identifying patient preferences, clearly explaining pertinent medical information, and developing consensus around a treatment plan.
-
The authors set out to determine whether daily bathing of patients with 2% chlorhexidine gluconate (CHG)-impregnated cloths could reduce central line-associated bloodstream infection (CLABSI) rate by at least 30% in a surgical ICU where CLABSI rates were above National Healthcare Safety Network averages.
-
In this issue: Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
The overwhelming majority of women who go through pregnancy never require admission to the intensive care unit.
-
-
In this issue: Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions.
-
Hyponatremia is frequently seen in patients with left ventricular failure and has recently been shown to be associated with right ventricular dysfunction and worse outcomes in patients with pulmonary hypertension.
-
Due to its lack of cardiovascular side effects, the short-acting non-barbiturate sedative, etomidate, has been one of the primary agents used to sedate hypotensive patients during rapid-sequence intubation (RSI).